Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on April 2, 2009
Schizophrenia Bulletin 2009 35(3):491-492; doi:10.1093/schbul/sbp014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/3/491    most recent
sbp014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Haan, S.
Right arrow Articles by Liu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Haan, S.
Right arrow Articles by Liu, X.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Chlorpromazine Dose for People With Schizophrenia

Saskia de Haan1,2 and Xiaomeng Liu2
2 University of Utrecht, UMC Utrecht, The Netherlands

Keywords: chlorpromazine / dose / meta-analysis

The first 10% of the full text of this article appears below.



    Background
 
Chlorpromazine is one of the 3 listed medicines for treating psychotic disorders in the World Health Organization's Essential Drug List. It is used across the globe for the 1% of people who suffer from this illness. Chlorpromazine has many adverse effects, including a range of movement disorders and anticholinergic and antihistaminic effects. Higher doses . . . [Full Text of this Article]


    Objectives
 

    Search Methods
 

    Selection Criteria
 

    Data Collection and Analysis
 

    Results
 

    Authors’ Conclusions
 
1 To whom correspondence should be addressed; tel: 00 31 64 28 10 903, e-mail: s.f.dehaan@students.uu.nl.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?